Information notices are available in Englishread more
Find the list of preindications in Englishread more

4 major issues

Organization of public health
Genomic medicine is revolutionising patient care pathways. Routine genome sequencing enables patients to receive personalised diagnostic and therapeutic care. This already applies to patients affected by certain rare diseases or cancers; ultimately, the aim of PFMG2025 is to extend access to genomic sequencing and personalised care to patients with more common diseases.
Scientific and clinical prospects
The aim is to structure and strengthen the continuum between care and research by accelerating research through the reuse of genomic data to improve understanding of diseases and develop new treatments, then transferring this new knowledge to care in order to improve diagnosis and patient management.
Technological progress
New technologies are set to converge with life and health sciences. The ability to acquire, store, distribute, match and interpret massive genomic data is at the heart of this convergence.
Economic dimension
Finally, there is an economic challenge, not only in terms of the sustainability of costs for our healthcare system, but also as a strategic opportunity to develop and structure a new industrial sector around partners already present in the field.